F
Feifan Yao
Publications - 3
Citations - 4
Feifan Yao is an academic researcher. The author has contributed to research in topics: Medicine & Hepatocellular carcinoma. The author has an hindex of 1, co-authored 3 publications receiving 4 citations.
Papers
More filters
Journal ArticleDOI
PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells
Qing V. Li,Liren Zhang,Wenhua You,Jiali Xu,Jingjing Dai,Dongxu Hua,Ruizhi Zhang,Feifan Yao,Suiqing Zhou,Wei Huang,Yongjiu Dai,Yu Zhang,Tasiken Baheti,Xiaofeng Qian,Liyong Pu,Jing Xu,Yongxiang Xia,Chuan-Shan Zhang,Jinhai Tang,Xuehao Wang +19 more
TL;DR: In this paper , the authors identify that tumoral Prdm1 overexpression inhibits cell growth in immune-deficient mouse models and demonstrate that the PRDM1-USP22-SPI1 axis regulates PD-L1 levels, resulting in infiltrated CD8 + T cell exhaustion.
Journal ArticleDOI
Etomidate elicits anti-tumor capacity by disrupting the JAK2/STAT3 signaling pathway in hepatocellular carcinoma.
Jiali Xu,Liren Zhang,Nana Li,Jingjing Dai,Dongxu Hua,Zifeng Wu,Huixuan Zhou,Ling Zhou,Ruizhi Zhang,Feifan Yao,Qing Li,Xuehao Wang,Cunming Liu +12 more
TL;DR: Wang et al. as discussed by the authors showed that etomidate significantly impedes the malignant progression of hepatocellular carcinoma (HCC) cells, by competing with ATP for binding to the ATP-binding pocket of JAK2.
Journal ArticleDOI
Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners.
Qing V. Li,Liren Zhang,Qin Yang,Mei Li,Xiongxiong Pan,Jiali Xu,Chen Zhong,Feifan Yao,Ruizhi Zhang,Suiqing Zhou,Xinzheng Dai,Xiaoli Shi,Yongjiu Dai,Jing-Hui Xu,Xu Cheng,Wenchang Xiao,Zhi-Gang She,Ke Wang,Xiaofeng Qian,Liyong Pu,Peng Zhang,Xuehao Wang +21 more
TL;DR: Using a large-scale transcriptomic database and survival correlation screening, Wang et al. as mentioned in this paper identified thymidine kinase 1 (TK1) as a key driver of hepatocellular carcinoma.